A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion
Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd.
Listed as NCT00308477, this PHASE1/PHASE2 trial focuses on Branch Retinal Vein Occlusion and Macular Degeneration and remains completed. Sponsored by Sanwa Kagaku Kenkyusho Co., Ltd., it has been updated 5 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Sanwa Kagaku Kenkyusho Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aichi, Japan , Chiba, Japan , Fukuoka, Japan , Gunma, Japan , Hokkaido, Japan , Kagawa, Japan , Kyoto, Japan , Mie, Japan , Miyazaki, Japan , Osaka, Japan and 2 more locations